August 12, 2019 10:11 AM EDT
Deals
R&D

Boehringer fol­lows the pop­u­lar KRAS trail to MD An­der­son — inks new al­liance on 'vir­tu­al' re­search cen­ter

John Carroll

Editor & Founder

Boehringer In­gel­heim is fol­low­ing the steadi­ly widen­ing KRAS trail to MD An­der­son.

In a new re­search pact an­nounced Mon­day morn­ing, the Ger­man phar­ma com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times